Publications

  1. Adedinsewo DA, Morales-Lara AC, Afolabi BB, Kushimo OA, Mbakwem AC, Ibiyemi KF, Ogunmodede JA, Raji HO, Ringim SH, Habib AA, Hamza SM, Ogah OS, Obajimi G, Saanu OO, Jagun OE, Inofomoh FO, Adeolu T, Karaye KM, Gaya SA, Alfa I, Yohanna C, Venkatachalam KL, Dugan J, Yao X, Sledge HJ, Johnson PW, Wieczorek MA, Attia ZI, Phillips SD, Yamani MH, Tobah YB, Rose CH, Sharpe EE, Lopez-Jimenez F, Friedman PA, Noseworthy PA, Carter RE, SPEC-AI Nigeria Investigators. Artificial intelligence guided screening for cardiomyopathies in an obstetric population: a pragmatic randomized clinical trial. Nat Med. 2024 Oct; 30 (10):2897-2906 Epub 2024 Sept 02
    View PubMed
  2. Challener DW, Tande AJ, Koutras C, Wade RL, McIntee MA, Strauss DM, Yao X, Chang YH, Berbari E. Evaluation of germicidal ultraviolet-C disinfection in a real-world outpatient health care environment. Am J Infect Control. 2024 Sep; 52 (9):1030-1034 Epub 2024 May 23
    View PubMed
  3. Yao X, Van Houten HK, Siontis KC, Friedman PA, McBane RD 2nd, Gersh BJ, Noseworthy PA. Ten-Year Trend of Oral Anticoagulation Use in Postoperative and Nonpostoperative Atrial Fibrillation in Routine Clinical Practice. J Am Heart Assoc. 2024 Jul 2; 13 (13):e035708 Epub 2024 June 27
    View PubMed
  4. Satterfield BA, Dikilitas O, Van Houten H, Yao X, Gersh BJ. Daylight Saving Time Practice and the Rate of Adverse Cardiovascular Events in the United States: A Probabilistic Assessment in a Large Nationwide Study. Mayo Clin Proc Innov Qual Outcomes. 2024 Feb; 8 (1):45-52 Epub 2024 Jan 05
    View PubMed
  5. Goldsweig AM, Deng Y, Yao X, Desai NR, Cohen DJ, Aronow HD, Messe SR, Ross JS, Lansky AJ, Savitz ST. Approval, Evidence, and "Off-Label" Device Utilization: The Patent Foramen Ovale Closure Story. Circ Cardiovasc Qual Outcomes. 2024 Jan; 17 (1):e010200 Epub 2024 Jan 08
    View PubMed
  6. Yao X, Attia ZI, Behnken EM, Hart MS, Inselman SA, Weber KC, Li F, Stricker NH, Stricker JL, Friedman PA, Noseworthy PA. Realtime Diagnosis from Electrocardiogram Artificial Intelligence-Guided Screening for Atrial Fibrillation with Long Follow-Up (REGAL): Rationale and design of a pragmatic, decentralized, randomized controlled trial. Am Heart J. 2024 Jan; 267:62-69 Epub 2023 Oct 30
    View PubMed
  7. Jin MF, Noseworthy PA, Yao X. Assessing artificial intelligence solution effectiveness: the role of pragmatic trials. Mayo Clinic Proceedings: Digital Health. 2024; 2 (4):499-510
  8. Agasthi P, Van Houten HK, Yao X, Jain CC, Egbe A, Warnes CA, Miranda WR, Dunlay SM, Stephens EH, Johnson JN, Connolly HM, Burchill LJ. Mortality and Morbidity of Heart Failure Hospitalization in Adult Patients With Congenital Heart Disease. J Am Heart Assoc. 2023 Dec 05; 12(23):e030649. Epub 2023 Nov 29.
    View PubMed
  9. Wallach JD, Deng Y, Polley EC, Dhruva SS, Herrin J, Quinto K, Gandotra C, Crown W, Noseworthy P, Yao X, Jeffery MM, Lyon TD, Ross JS, McCoy RG. Assessing the use of observational methods and real-world data to emulate ongoing randomized controlled trials. Clin Trials. 2023 Dec; 20 (6):689-698 Epub 2023 Aug 17
    View PubMed
  10. Kir D, Van Houten HK, Walvatne KN, Behnken EM, Alkhouli MA, Graff-Radford J, Melduni RM, Gersh BJ, Friedman PA, Shah ND, Noseworthy PA, Yao X. Physicians' perspectives on percutaneous left atrial appendage occlusion for patients with atrial fibrillation. Am Heart J. 2023 Dec; 266:14-24 Epub 2023 Aug 10
    View PubMed
  11. Harmon DM, Noseworthy PA, Yao X. The Digitization and Decentralization of Clinical Trials. Mayo Clin Proc. 2023 Oct; 98 (10):1568-1578 Epub 2023 Jan 18
    View PubMed
  12. Le-Rademacher J, Gunn H, Yao X, Schaid DJ. Clinical Trials Overview: From Explanatory to Pragmatic Clinical Trials. Mayo Clin Proc. 2023 Aug; 98 (8):1241-1253
    View PubMed
  13. Alkhouli M, Van Houten HK, Yao X, Holmes DR. Effectiveness of Transcatheter Closure of Patent Foramen Ovale in Clinical Practice. J Am Heart Assoc. 2023 Aug; 12 (15):e030321 Epub 2023 July 25
    View PubMed
  14. Riaz IB, Fuentes H, Deng Y, Naqvi SAA, Yao X, Sangaralingham LR, Houghton DE, Padrnos LJ, Shamoun FE, Wysokinski WE, McBane RD 2nd. Comparative Effectiveness of Anticoagulants in Patients With Cancer-Associated Thrombosis. JAMA Netw Open. 2023 Jul 3; 6 (7):e2325283 Epub 2023 July 03
    View PubMed
  15. Adedinsewo DA, Morales-Lara AC, Dugan J, Garzon-Siatoya WT, Yao X, Johnson PW, Douglass EJ, Attia ZI, Phillips SD, Yamani MH, Tobah YB, Rose CH, Sharpe EE, Lopez-Jimenez F, Friedman PA, Noseworthy PA, Carter RE. Screening for peripartum cardiomyopathies using artificial intelligence in Nigeria (SPEC-AI Nigeria): Clinical trial rationale and design. Am Heart J. 2023 Jul; 261:64-74. Epub 2023 Mar 25.
    View PubMed
  16. Ngufor C, Yao X, Inselman JW, Ross JS, Dhruva SS, Graham DJ, Lee JY, Siontis KC, Desai NR, Polley E, Shah ND, Noseworthy PA. Identifying treatment heterogeneity in atrial fibrillation using a novel causal machine learning method. Am Heart J. 2023 Jun; 260:124-140 Epub 2023 Mar 07
    View PubMed
  17. Sehrawat O, Kashou AH, Van Houten HK, Cohen K, Joe Henk H, Gersh BJ, Abraham NS, Graff-Radford J, Friedman PA, Siontis KC, Noseworthy PA, Yao X. Contemporary trends and barriers to oral anticoagulation therapy in Non-valvular atrial fibrillation during DOAC predominant era. Int J Cardiol Heart Vasc. 2023 Jun; 46:101212 Epub 2023 Apr 25
    View PubMed
  18. Dickow J, Kany S, Roth Cardoso V, Ellinor PT, Gkoutos GV, Van Houten HK, Kirchhof P, Metzner A, Noseworthy PA, Yao X, Rillig A. Outcomes of Early Rhythm Control Therapy in Patients With Atrial Fibrillation and a High Comorbidity Burden in Large Real-World Cohorts. Circ Arrhythm Electrophysiol. 2023 May; 16 (5):e011585 Epub 2023 Mar 21
    View PubMed
  19. Jentzer JC, Lawler PR, Van Houten HK, Yao X, Kashani KB, Dunlay SM. Cardiovascular Events Among Survivors of Sepsis Hospitalization: A Retrospective Cohort Analysis. J Am Heart Assoc. 2023 Feb 7; 12 (3):e027813 Epub 2023 Feb 01
    View PubMed
  20. Wi CI, King KS, Ryu E, Natoli TL, Miller RP, Spiten MJ, Borah BJ, Takahashi PY, Yao X, Noseworthy PA, Pignolo RJ, Juhn YJ. Application of Innovative Subject Recruitment System for Batch Enrollment: A Pilot Study. J Prim Care Community Health. 2023 Jan-Dec; 14:21501319231194967
    View PubMed
  21. Attia ZI, Harmon DM, Dugan J, Manka L, Lopez-Jimenez F, Lerman A, Siontis KC, Noseworthy PA, Yao X, Klavetter EW, Halamka JD, Asirvatham SJ, Khan R, Carter RE, Leibovich BC, Friedman PA. Prospective evaluation of smartwatch-enabled detection of left ventricular dysfunction. Nat Med. 2022 Dec; 28 (12):2497-2503 Epub 2022 Nov 14
    View PubMed
  22. Rushlow DR, Croghan IT, Inselman JW, Thacher TD, Friedman PA, Yao X, Pellikka PA, Lopez-Jimenez F, Bernard ME, Barry BA, Attia IZ, Misra A, Foss RM, Molling PE, Rosas SL, Noseworthy PA. Clinician Adoption of an Artificial Intelligence Algorithm to Detect Left Ventricular Systolic Dysfunction in Primary Care. Mayo Clin Proc. 2022 Nov; 97 (11):2076-2085
    View PubMed
  23. Barry B, Zhu X, Behnken E, Inselman J, Schaepe K, McCoy R, Rushlow D, Noseworthy P, Richardson J, Curtis S, Sharp R, Misra A, Akfaly A, Molling P, Bernard M, Yao X. Provider Perspectives on Artificial Intelligence-Guided Screening for Low Ejection Fraction in Primary Care: Qualitative Study. JMIR AI. 2022 Oct 14; 1 (1):e41940
    View PubMed
  24. Noseworthy PA, Attia ZI, Behnken EM, Giblon RE, Bews KA, Liu S, Gosse TA, Linn ZD, Deng Y, Yin J, Gersh BJ, Graff-Radford J, Rabinstein AA, Siontis KC, Friedman PA, Yao X. Artificial intelligence-guided screening for atrial fibrillation using electrocardiogram during sinus rhythm: a prospective non-randomised interventional trial. Lancet. 2022 Oct 8; 400 (10359):1206-1212 Epub 2022 Sept 27
    View PubMed
  25. Noseworthy PA, Van Houten HK, Krumholz HM, Kent DM, Abraham NS, Graff-Radford J, Alkhouli M, Henk HJ, Shah ND, Gersh BJ, Friedman PA, Holmes DR Jr, Yao X. Percutaneous Left Atrial Appendage Occlusion in Comparison to Non-Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation. J Am Heart Assoc. 2022 Oct 4; 11 (19):e027001 Epub 2022 Sept 29
    View PubMed
  26. Deng Y, Polley EC, Wallach JD, Dhruva SS, Herrin J, Quinto K, Gandotra C, Crown W, Noseworthy P, Yao X, Lyon TD, Shah ND, Ross JS, McCoy RG. Emulating the GRADE trial using real world data: retrospective comparative effectiveness study. BMJ. 2022 Oct 3; 379:e070717 Epub 2022 Oct 03
    View PubMed
  27. Yao X, Paulson M, Maniaci MJ, Dunn AN, Nelson CR, Behnken EM, Hart MS, Sangaralingham LR, Inselman SA, Lampman MA, Dunlay SM, Dowdy SC, Habermann EB. Effect of hospital-at-home vs. traditional brick-and-mortar hospital care in acutely ill adults: study protocol for a pragmatic randomized controlled trial. Trials. 2022 Jun 16; 23 (1):503 Epub 2022 June 16
    View PubMed
  28. Dickow J, Kirchhof P, Van Houten HK, Sangaralingham LR, Dinshaw LHW, Friedman PA, Packer DL, Noseworthy PA, Yao X. Generalizability of the EAST-AFNET 4 Trial: Assessing Outcomes of Early Rhythm-Control Therapy in Patients With Atrial Fibrillation. J Am Heart Assoc. 2022 Jun 7; 11 (11):e024214 Epub 2022 May 27
    View PubMed
  29. Christopoulos G, Attia ZI, Van Houten HK, Yao X, Carter RE, Lopez-Jimenez F, Kapa S, Noseworthy PA, Friedman PA. Artificial intelligence-electrocardiography to detect atrial fibrillation: trend of probability before and after the first episode. Eur Heart J Digit Health. 2022 Jun; 3 (2):228-235 Epub 2022 May 09
    View PubMed
  30. Weil EL, Noseworthy PA, Lopez CL, Rabinstein AA, Friedman PA, Attia ZI, Yao X, Siontis KC, Kremers WK, Christopoulos G, Mielke MM, Vemuri P, Jack CR Jr, Gersh BJ, Machulda MM, Knopman DS, Petersen RC, Graff-Radford J. Artificial Intelligence-Enabled Electrocardiogram for Atrial Fibrillation Identifies Cognitive Decline Risk and Cerebral Infarcts. Mayo Clin Proc. 2022 May; 97 (5):871-880
    View PubMed
  31. Enayati M, Zanjirani N, Scott C, Bos JM, Yao X, Ngufor C, Ackerman MJ, Arruda-Olson A. Unsupervised Clustering of Sparse Echo Data to Identify Patients for Implantation of Cardioverter-Defibrillator Proceedings of the 2022 Design of Medical Devices Conference, DMD 2022 Article V001T01A008 (Proceedings of the 2022 Design of Medical Devices Conference, DMD 2022). American Society of Mechanical Engineers. https://doi.org/10.1115/DMD2022-1074. 2022.
  32. Adedinsewo DA, Pollak AW, Phillips SD, Smith TL, Svatikova A, Hayes SN, Mulvagh SL, Norris C, Roger VL, Noseworthy PA, Yao X, Carter RE. Cardiovascular Disease Screening in Women: Leveraging Artificial Intelligence and Digital Tools. Circ Res. 2022 Feb 18; 130 (4):673-690 Epub 2022 Feb 17
    View PubMed
  33. Brito JP, Ross JS, Deng Y, Sangaralingham L, Graham DJ, Qiang Y, Wang Z, Yao X, Zhao L, Smallridge RC, Bernet V, Shah ND, Lipska KJ. Cardiovascular outcomes and rates of fractures and falls among patients with brand-name versus generic L-thyroxine use. Endocrine. 2021 Dec; 74 (3):592-602 Epub 2021 June 05
    View PubMed
  34. Wallach JD, Deng Y, McCoy RG, Dhruva SS, Herrin J, Berkowitz A, Polley EC, Quinto K, Gandotra C, Crown W, Noseworthy P, Yao X, Shah ND, Ross JS, Lyon TD. Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment. JAMA Netw Open. 2021 Oct 1; 4 (10):e2130587 Epub 2021 Oct 01
    View PubMed
  35. Rabinstein AA, Yost MD, Faust L, Kashou AH, Latif OS, Graff-Radford J, Attia IZ, Yao X, Noseworthy PA, Friedman PA. Artificial Intelligence-Enabled ECG to Identify Silent Atrial Fibrillation in Embolic Stroke of Unknown Source. J Stroke Cerebrovasc Dis. 2021 Sep; 30 (9):105998 Epub 2021 July 22
    View PubMed
  36. Yao X, Attia ZI, Behnken EM, Walvatne K, Giblon RE, Liu S, Siontis KC, Gersh BJ, Graff-Radford J, Rabinstein AA, Friedman PA, Noseworthy PA. Batch enrollment for an artificial intelligence-guided intervention to lower neurologic events in patients with undiagnosed atrial fibrillation: rationale and design of a digital clinical trial. Am Heart J. 2021 Sep; 239:73-79 Epub 2021 May 24
    View PubMed
  37. McCoy RG, Van Houten HK, Dunlay SM, Yao X, Dempsey T, Noseworthy PA, Sangaralingham LR, Limper AH, Shah ND. Race and sex differences in the initiation of diabetes drugs by privately insured US adults. Endocrine 2021 Aug; 73 (2):480-484 Epub 2021 Apr 08
    View PubMed
  38. Tseng AS, Thao V, Borah BJ, Attia IZ, Medina Inojosa J, Kapa S, Carter RE, Friedman PA, Lopez-Jimenez F, Yao X, Noseworthy PA. Cost Effectiveness of an Electrocardiographic Deep Learning Algorithm to Detect Asymptomatic Left Ventricular Dysfunction. Mayo Clin Proc. 2021 Jul; 96 (7):1835-1844 Epub 2021 June 09
    View PubMed
  39. Dempsey TM, Payne S, Sangaralingham L, Yao X, Shah ND, Limper AH. Adoption of the Antifibrotic Medications Pirfenidone and Nintedanib for Patients with Idiopathic Pulmonary Fibrosis. Ann Am Thorac Soc. 2021 Jul; 18 (7):1121-1128
    View PubMed
  40. Ashraf H, Agasthi P, Shanbhag A, Mehta RA, Rattanawong P, Allam M, Pujari SH, Mookadam F, Freeman WK, Srivathsan K, Sorajja D, Shen WK, Noseworthy PA, Yang EH, Masry HZE, Yao X, Mulpuru SK, Beohar N, Holmes DR Jr, Arsanjani R. Long-Term Clinical Outcomes of Underdosed Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Atrial Flutter. Am J Med. 2021 Jun; 134(6):788-796. Epub 2021 Jan 12.
    View PubMed
  41. Herrin J, Abraham NS, Yao X, Noseworthy PA, Inselman J, Shah ND, Ngufor C. Comparative Effectiveness of Machine Learning Approaches for Predicting Gastrointestinal Bleeds in Patients Receiving Antithrombotic Treatment. JAMA Netw Open. 2021 May 3; 4 (5):e2110703 Epub 2021 May 03
    View PubMed
  42. Yao X, Rushlow DR, Inselman JW, McCoy RG, Thacher TD, Behnken EM, Bernard ME, Rosas SL, Akfaly A, Misra A, Molling PE, Krien JS, Foss RM, Barry BA, Siontis KC, Kapa S, Pellikka PA, Lopez-Jimenez F, Attia ZI, Shah ND, Friedman PA, Noseworthy PA. Artificial intelligence-enabled electrocardiograms for identification of patients with low ejection fraction: a pragmatic, randomized clinical trial. Nat Med. 2021 May; 27 (5):815-819 Epub 2021 May 06
    View PubMed
  43. Enayati M, Zanjirani N, Scott C, Bos J, Yao X, Ngufor C, Arruda-Olson A. Deep Unsupervised Clustering of Sparse Echo Data to Identify Patients for Implantation of Cardioverter-Defibrillator 2021 Design of Medical Devices Conference.. 2021.
  44. Duncker D, Ding WY, Etheridge S, Noseworthy PA, Veltmann C, Yao X, Bunch TJ, Gupta D. Smart Wearables for Cardiac Monitoring-Real-World Use beyond Atrial Fibrillation. Sensors (Basel). 2021 Apr 5; 21 (7) Epub 2021 Apr 05
    View PubMed
  45. Tan NY, Deng Y, Yao X, Sangaralingham LR, Shah ND, Rule AD, Burnett JC Jr, Dunlay SM, Sangaralingham SJ. Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker. Mayo Clin Proc Innov Qual Outcomes. 2021 Apr; 5 (2):286-297 Epub 2021 Feb 15
    View PubMed
  46. Jackson CL, Deng Y, Yao X, Van Houten H, Shah ND, Kopecky S. Proprotein convertase subtilisin/kexin type 9 inhibitor utilization and low-density lipoprotein-cholesterol control in familial hypercholesterolemia. J Clin Lipidol. 2021 Mar-Apr; 15 (2):339-346 Epub 2020 Dec 27
    View PubMed
  47. Pennington KM, Dykhoff HJ, Yao X, Sangaralingham LR, Shah ND, Peters SG, Barreto JN, Razonable RR, Kennedy CC. The Impact of Antifungal Prophylaxis in Lung Transplant Recipients. Ann Am Thorac Soc. 2021 Mar; 18 (3):468-476
    View PubMed
  48. Christopoulos G, Graff-Radford J, Lopez CL, Yao X, Attia ZI, Rabinstein AA, Petersen RC, Knopman DS, Mielke MM, Kremers W, Vemuri P, Siontis KC, Friedman PA, Noseworthy PA. Artificial Intelligence-Electrocardiography to Predict Incident Atrial Fibrillation: A Population-Based Study. Circ Arrhythm Electrophysiol. 2020 Dec; 13 (12):e009355 Epub 2020 Nov 13
    View PubMed
  49. Hendricks AK, Zieminski JJ, Yao X, Dunlay SM, Sangaralingham LR, O'Meara JG, Herrin TR, Nei SD. Safety and Efficacy of Oral Anticoagulants for Atrial Fibrillation in Patients After Bariatric Surgery. Am J Cardiol. 2020 Dec 1; 136:76-80 Epub 2020 Sept 15
    View PubMed
  50. Yao X, Shah ND, Gersh BJ, Lopez-Jimenez F, Noseworthy PA. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016. JAMA Netw Open. 2020 Nov 2; 3 (11):e2025505 Epub 2020 Nov 02
    View PubMed
  51. Vallabhajosyula S, Payne SR, Jentzer JC, Sangaralingham LR, Yao X, Kashani K, Shah ND, Prasad A, Dunlay SM. Long-Term Outcomes of Acute Myocardial Infarction With Concomitant Cardiogenic Shock and Cardiac Arrest. Am J Cardiol. 2020 Oct 15; 133:15-22 Epub 2020 July 28
    View PubMed
  52. Yao X, Inselman JW, Ross JS, Izem R, Graham DJ, Martin DB, Thompson AM, Ross Southworth M, Siontis KC, Ngufor CG, Nath KA, Desai NR, Nallamothu BK, Saran R, Shah ND, Noseworthy PA. Comparative Effectiveness and Safety of Oral Anticoagulants Across Kidney Function in Patients With Atrial Fibrillation. Circ Cardiovasc Qual Outcomes. 2020 Oct; 13 (10):e006515 Epub 2020 Oct 05
    View PubMed
  53. Brito JP, Ross JS, Sangaralingham L, Dutcher SK, Graham DJ, Wang Z, Wu Y, Yao X, Smallridge RC, Bernet V, Shah ND, Lipska KJ. Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Achieving Normal Thyrotropin Levels. JAMA Netw Open. 2020 Sep 1; 3 (9):e2017645 Epub 2020 Sept 01
    View PubMed
  54. Abraham NS, Yang EH, Noseworthy PA, Inselman J, Yao X, Herrin J, Sangaralingham LR, Ngufor C, Shah ND. Fewer gastrointestinal bleeds with ticagrelor and prasugrel compared with clopidogrel in patients with acute coronary syndrome following percutaneous coronary intervention. Aliment Pharmacol Ther. 2020 Aug; 52 (4):646-654 Epub 2020 July 13
    View PubMed
  55. Noseworthy PA, Van Houten HK, Gersh BJ, Packer DL, Friedman PA, Shah ND, Dunlay SM, Siontis KC, Piccini JP, Yao X. Generalizability of the CASTLE-AF trial: Catheter ablation for patients with atrial fibrillation and heart failure in routine practice. Heart Rhythm. 2020 Jul; 17 (7):1057-1065 Epub 2020 Mar 04
    View PubMed
  56. Siontis KC, Yao X, Pirruccello JP, Philippakis AA, Noseworthy PA. How Will Machine Learning Inform the Clinical Care of Atrial Fibrillation? Circ Res. 2020 Jun 19; 127 (1):155-169 Epub 2020 June 18
    View PubMed
  57. Kundi H, Noseworthy PA, Valsdottir LR, Shen C, Yao X, Yeh RW, Kramer DB. Relation of Frailty to Outcomes After Catheter Ablation of Atrial Fibrillation. Am J Cardiol. 2020 May 1; 125 (9):1317-1323 Epub 2020 Feb 08
    View PubMed
  58. Noseworthy PA, Attia ZI, Brewer LC, Hayes SN, Yao X, Kapa S, Friedman PA, Lopez-Jimenez F. Assessing and Mitigating Bias in Medical Artificial Intelligence: The Effects of Race and Ethnicity on a Deep Learning Model for ECG Analysis. Circ Arrhythm Electrophysiol. 2020 Mar; 13 (3):e007988 Epub 2020 Feb 16
    View PubMed
  59. Porter SB, Glasgow AE, Yao X, Habermann EB. Association of Florida House Bill 21 With Postoperative Opioid Prescribing for Acute Pain at a Single Institution. JAMA Surg 2020 Mar 1; 155 (3):263-264
    View PubMed
  60. Siontis KC, Checkole S, Yao X, Gersh BJ, Noseworthy PA. Do Observational Studies Agree With Randomized Trials?: Evaluation of Oral Anticoagulants in Atrial Fibrillation. J Am Coll Cardiol 2020 Feb 11; 75 (5):562-563
    View PubMed
  61. Abraham NS, Noseworthy PA, Inselman J, Herrin J, Yao X, Sangaralingham LR, Cornish G, Ngufor C, Shah ND. Risk of Gastrointestinal Bleeding Increases With Combinations of Antithrombotic Agents and Patient Age. Clin Gastroenterol Hepatol. 2020 Feb; 18 (2):337-346.e19 Epub 2019 May 18
    View PubMed
  62. Yao X, McCoy RG, Friedman PA, Shah ND, Barry BA, Behnken EM, Inselman JW, Attia ZI, Noseworthy PA. Clinical trial design data for electrocardiogram artificial intelligence-guided screening for low ejection fraction (EAGLE). Data Brief. 2020 Feb; 28:104894 Epub 2019 Nov 27
    View PubMed
  63. Tan NY, Sangaralingham LR, Sangaralingham SJ, Yao X, Shah ND, Dunlay SM. Comparative Effectiveness of Sacubitril-Valsartan Versus ACE/ARB Therapy in Heart Failure With Reduced Ejection Fraction. JACC Heart Fail. 2020 Jan; 8 (1):43-54 Epub 2019 Dec 11
    View PubMed
  64. Akar JG, Hummel JP, Yao X, Sangaralingham L, Dhruva S, Dong J, Ward R, Shah ND, Ross J, Noseworthy PA. Catheter-related complications and mortality of atrial fibrillation ablation following introduction of contact force-sensing technology. BMJ Surg Interv Health Technol. 2020; 2 (1):e000058 Epub 2020 Dec 29
    View PubMed
  65. Yao X, McCoy RG, Friedman PA, Shah ND, Barry BA, Behnken EM, Inselman JW, Attia ZI, Noseworthy PA. ECG AI-Guided Screening for Low Ejection Fraction (EAGLE): Rationale and design of a pragmatic cluster randomized trial. Am Heart J. 2020 Jan; 219:31-36 Epub 2019 Oct 25
    View PubMed
  66. Noseworthy PA, Kaufman ES, Chen LY, Chung MK, Elkind MSV, Joglar JA, Leal MA, McCabe PJ, Pokorney SD, Yao X, American Heart Association Council on Clinical Cardiology Electrocardiography and Arrhythmias Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and Stroke Council. Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association. Circulation. 2019 Dec 17; 140 (25):e944-e963 Epub 2019 Nov 07
    View PubMed
  67. DuBose-Briski V, Yao X, Dunlay SM, Dhruva SS, Ross JS, Shah ND, Noseworthy PA. Evolution of the American College of Cardiology and American Heart Association Cardiology Clinical Practice Guidelines: A 10-Year Assessment. J Am Heart Assoc. 2019 Oct; 8(19):e012065. Epub 2019 Sep 28.
    View PubMed
  68. Attia ZI, Noseworthy PA, Lopez-Jimenez F, Asirvatham SJ, Deshmukh AJ, Gersh BJ, Carter RE, Yao X, Rabinstein AA, Erickson BJ, Kapa S, Friedman PA. An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction. Lancet. 2019 Sep 7; 394 (10201):861-867 Epub 2019 Aug 01
    View PubMed
  69. Maraka S, Mwangi R, Yao X, Sangaralingham LR, Singh Ospina NM, O'Keeffe DT, Rodriguez-Gutierrez R, Stan MN, Brito JP, Montori VM, McCoy RG. Variation in Treatment Practices for Subclinical Hypothyroidism in Pregnancy: US National Assessment. J Clin Endocrinol Metab. 2019 Sep 1; 104 (9):3893-3901
    View PubMed
  70. Dempsey TM, Sangaralingham LR, Yao X, Sanghavi D, Shah ND, Limper AH. Clinical Effectiveness of Antifibrotic Medications for Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019 Jul 15; 200 (2):168-174
    View PubMed
  71. Shah PH, Leibovich BC, Van Houten H, Lyon TD, Yao X, Knoedler M, Sangaralingham L, Kattah A, Thompson RH, Shah ND, Boorjian SA. Association of Partial versus Radical Nephrectomy with Subsequent Hypertension Risk Following Renal Tumor Resection. J Urol. 2019 Jul; 202 (1):69-75 Epub 2019 June 07
    View PubMed
  72. Ross JS, Rohde S, Sangaralingham L, Brito JP, Choi L, Dutcher SK, Graham DJ, Jenkins MR, Lipska KJ, Mendoza M, Qiang Y, Wang Z, Wu Y, Yao X, Shah ND. Generic and Brand-Name Thyroid Hormone Drug Use Among Commercially Insured and Medicare Beneficiaries, 2007 Through 2016. J Clin Endocrinol Metab. 2019 Jun 1; 104 (6):2305-2314
    View PubMed
  73. Attia ZI, Kapa S, Yao X, Lopez-Jimenez F, Mohan TL, Pellikka PA, Carter RE, Shah ND, Friedman PA, Noseworthy PA. Prospective validation of a deep learning electrocardiogram algorithm for the detection of left ventricular systolic dysfunction. J Cardiovasc Electrophysiol. 2019 May; 30 (5):668-674 Epub 2019 Mar 10
    View PubMed
  74. El-Harasis MA, DeSimone CV, Yao X, Noseworthy PA. Prediction and Management of Recurrences after Catheter Ablation in Atrial Fibrillation and Heart Failure. Cardiol Clin. 2019 May; 37 (2):221-230 Epub 2019 Feb 12
    View PubMed
  75. Noseworthy PA, Gersh BJ, Kent DM, Piccini JP, Packer DL, Shah ND, Yao X. Atrial fibrillation ablation in practice: assessing CABANA generalizability. Eur Heart J. 2019 Apr 21; 40 (16):1257-1264
    View PubMed
  76. Yao X, Gersh BJ, Lopez-Jimenez F, Shah ND, Noseworthy PA. Generalizability of the FOURIER trial to routine clinical care: Do trial participants represent patients in everyday practice? Am Heart J. 2019 Mar; 209:54-62 Epub 2018 Dec 16
    View PubMed
  77. Johnsrud DO, Melduni RM, Lahr B, Yao X, Greason KL, Noseworthy PA. Evaluation of anticoagulation use and subsequent stroke in patients with atrial fibrillation after empiric surgical left atrial appendage closure: A retrospective case-control study. Clin Cardiol. 2018 Dec; 41 (12):1578-1582 Epub 2018 Dec 10
    View PubMed
  78. Siontis KC, Zhang X, Eckard A, Bhave N, Schaubel DE, He K, Tilea A, Stack AG, Balkrishnan R, Yao X, Noseworthy PA, Shah ND, Saran R, Nallamothu BK. Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States. Circulation. 2018 Oct 9; 138 (15):1519-1529
    View PubMed
  79. Sabbag A, Yao X, Siontis KC, Noseworthy PA. Anticoagulation for Stroke Prevention in Older Adults with Atrial Fibrillation and Comorbidity: Current Evidence and Treatment Challenges. Korean Circ J. 2018 Oct; 48 (10):873-889
    View PubMed
  80. Yao X, Gersh BJ, Holmes DR Jr, Melduni RM, Johnsrud DO, Sangaralingham LR, Shah ND, Noseworthy PA. Association of Surgical Left Atrial Appendage Occlusion With Subsequent Stroke and Mortality Among Patients Undergoing Cardiac Surgery. JAMA. 2018 May 22; 319 (20):2116-2126
    View PubMed
  81. Yao X, Gersh BJ, Sangaralingham LR, Shah ND, Noseworthy PA. Risk of cardiovascular events and incident atrial fibrillation in patients without prior atrial fibrillation: Implications for expanding the indications for anticoagulation. Am Heart J. 2018 May; 199:137-143 Epub 2018 Feb 10
    View PubMed
  82. Tollefson MM, Van Houten HK, Asante D, Yao X, Maradit Kremers H. Association of Psoriasis With Comorbidity Development in Children With Psoriasis. JAMA Dermatol. 2018 Mar 1; 154 (3):286-292
    View PubMed
  83. Sangaralingham LR, Sangaralingham SJ, Shah ND, Yao X, Dunlay SM. Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure. Circ Heart Fail. 2018 Feb; 11 (2):e004302
    View PubMed
  84. Yao X, Tangri N, Gersh BJ, Sangaralingham LR, Shah ND, Nath KA, Noseworthy PA. Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation. J Am Coll Cardiol. 2017 Nov 28; 70 (21):2621-2632
    View PubMed
  85. Yao X, Gersh BJ, Sangaralingham LR, Kent DM, Shah ND, Abraham NS, Noseworthy PA. Comparison of the CHA2DS2-VASc, CHADS2, HAS-BLED, ORBIT, and ATRIA Risk Scores in Predicting Non-Vitamin K Antagonist Oral Anticoagulants-Associated Bleeding in Patients With Atrial Fibrillation. Am J Cardiol. 2017 Nov 1; 120 (9):1549-1556 Epub 2017 July 31
    View PubMed
  86. Borah BJ, Yao X, Laughlin-Tommaso SK, Heien HC, Stewart EA. Comparative Effectiveness of Uterine Leiomyoma Procedures Using a Large Insurance Claims Database. Obstet Gynecol. 2017 Nov; 130 (5):1047-1056
    View PubMed
  87. Noseworthy PA, Yao X, Gersh BJ, Hargraves I, Shah ND, Montori VM. Long-term stroke and bleeding risk in patients with atrial fibrillation treated with oral anticoagulants in contemporary practice: Providing evidence for shared decision-making. Int J Cardiol. 2017 Oct 15; 245:174-177. Epub 2017 Jul 14.
    View PubMed
  88. Noseworthy PA, Yao X, Gersh BJ, Hargraves I, Shah ND, Montori VM. Baseline characteristics and event rates among anticoagulated patients with atrial fibrillation in practice and pivotal NOAC trials. Data Brief. 2017 Oct; 14:563-565. Epub 2017 Aug 09.
    View PubMed
  89. Yao X, Shah ND, Sangaralingham LR, Gersh BJ, Noseworthy PA. Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction. J Am Coll Cardiol. 2017 Jun 13; 69 (23):2779-2790
    View PubMed
  90. Lipska KJ, Yao X, Herrin J, McCoy RG, Ross JS, Steinman MA, Inzucchi SE, Gill TM, Krumholz HM, Shah ND. Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013. Diabetes Care. 2017 Apr; 40 (4):468-475 Epub 2016 Sept 22
    View PubMed
  91. Abraham NS, Noseworthy PA, Yao X, Sangaralingham LR, Shah ND. Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study. Gastroenterology. 2017 Apr; 152 (5):1014-1022.e1 Epub 2016 Dec 30
    View PubMed
  92. Siontis KC, Yao X, Gersh BJ, Noseworthy PA. Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease Other Than Significant Mitral Stenosis and Mechanical Valves: A Meta-Analysis. Circulation 2017 Feb 14; 135 (7):714-716
    View PubMed
  93. Maraka S, Mwangi R, McCoy RG, Yao X, Sangaralingham LR, Singh Ospina NM, O'Keeffe DT, De Ycaza AE, Rodriguez-Gutierrez R, Coddington CC 3rd, Stan MN, Brito JP, Montori VM. Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment. BMJ. 2017 Jan 25; 356:i6865
    View PubMed
  94. Yao X, Stewart EA, Laughlin-Tommaso SK, Heien HC, Borah BJ. Medical therapies for heavy menstrual bleeding in women with uterine fibroids: a retrospective analysis of a large commercially insured population in the USA. BJOG. 2017 Jan; 124 (2):322-330 Epub 2016 Oct 21
    View PubMed
  95. Noseworthy PA, Yao X, Abraham NS, Sangaralingham LR, McBane RD, Shah ND. Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation. Chest. 2016 Dec; 150 (6):1302-1312 Epub 2016 Sept 28
    View PubMed
  96. Dembe AE, Yao X. Chronic Disease Risks From Exposure to Long-Hour Work Schedules Over a 32-Year Period. J Occup Environ Med. 2016 Sep; 58 (9):861-7
    View PubMed
  97. Del-Carpio Munoz F, Yao X, Abraham NS, Bellolio MF, Rabinstein AA, Asirvatham SJ, McBane RD, Gersh BJ, Shah ND, Noseworthy PA. Dabigatran Versus Warfarin in Relation to Renal Function in Patients With Atrial Fibrillation. J Am Coll Cardiol 2016 Jul 5; 68 (1):129-31
    View PubMed
  98. McCoy RG, Lipska KJ, Yao X, Ross JS, Montori VM, Shah ND. Intensive Treatment and Severe Hypoglycemia Among Adults With Type 2 Diabetes. JAMA Intern Med. 2016 Jul 1; 176 (7):969-78
    View PubMed
  99. Noseworthy PA, Yao X, Shah ND, Gersh BJ. Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation. J Am Coll Cardiol 2016 Jun 28; 67 (25):3020-1
    View PubMed
  100. Yao X, Abraham NS, Sangaralingham LR, Bellolio MF, McBane RD, Shah ND, Noseworthy PA. Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation. J Am Heart Assoc. 2016 Jun 13; 5 (6) Epub 2016 June 13
    View PubMed
  101. Sangaralingham LR, Shah ND, Yao X, Roger VL, Dunlay SM. Incidence and Early Outcomes of Heart Failure in Commercially Insured and Medicare Advantage Patients, 2006 to 2014. Circ Cardiovasc Qual Outcomes. 2016 May; 9 (3):332-7 Epub 2016 May 10
    View PubMed
  102. Noseworthy PA, Yao X, Shah ND, Gersh BJ. Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease. Int J Cardiol 2016 Apr 15; 209:181-3 Epub 2016 Feb 02
    View PubMed
  103. Madhavan M, Yao X, Sangaralingham LR, Asirvatham SJ, Friedman PA, McLeod CJ, Sugrue AM, DeSimone CV, Noseworthy PA. Ischemic Stroke or Systemic Embolism After Transseptal Ablation of Arrhythmias in Patients With Cardiac Implantable Electronic Devices. J Am Heart Assoc. 2016 Apr 13; 5 (4):e003163
    View PubMed
  104. Yao X, Abraham NS, Alexander GC, Crown W, Montori VM, Sangaralingham LR, Gersh BJ, Shah ND, Noseworthy PA. Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation. J Am Heart Assoc. 2016 Feb 23; 5 (2)
    View PubMed
  105. Borah BJ, Laughlin-Tommaso SK, Myers ER, Yao X, Stewart EA. Association Between Patient Characteristics and Treatment Procedure Among Patients With Uterine Leiomyomas. Obstet Gynecol. 2016 Jan; 127 (1):67-77
    View PubMed
  106. Deshmukh AJ, Yao X, Schilz S, Van Houten H, Sangaralingham LR, Asirvatham SJ, Friedman PA, Packer DL, Noseworthy PA. Pacemaker implantation after catheter ablation for atrial fibrillation. J Interv Card Electrophysiol. 2016 Jan; 45 (1):99-105 Epub 2015 Nov 06
    View PubMed
  107. Al-Hijji MA, Deshmukh AJ, Yao X, Mwangi R, Sangaralingham LR, Friedman PA, Asirvatham SJ, Packer DL, Shah ND, Noseworthy PA. Trends and predictors of repeat catheter ablation for atrial fibrillation. Am Heart J. 2016 Jan; 171: (1)48-55.
    View PubMed
  108. Yao X, Sangaralingham LR, Ross JS, Shah ND, Talwalkar JA. Adoption of new agents and changes in treatment patterns for hepatitis C: 2010-2014. Am J Manag Care. 2016; 22: (6)e224-32.
    View PubMed
  109. Noseworthy PA, Yao X, Deshmukh AJ, Van Houten H, Sangaralingham LR, Siontis KC, Piccini JP Sr, Asirvatham SJ, Friedman PA, Packer DL, Gersh BJ, Shah ND. Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation. J Am Heart Assoc. 2015 Nov 5; 4 (11) Epub 2015 Nov 05
    View PubMed
  110. Yao X, Dembe AE, Wickizer T, Lu B. Does time pressure create barriers for people to receive preventive health services? Prev Med. 2015 May; 74:55-8 Epub 2015 Mar 12
    View PubMed
  111. Borah BJ, Egginton JS, Shah ND, Wagie AE, Olsen KD, Yao X, Lopez-Jimenez F. Association of worksite wellness center attendance with weight loss and health care cost savings: Mayo Clinic's experience. J Occup Environ Med. 2015 Mar; 57: (3)229-34.
    View PubMed
  112. Dembe AE, Yao X, Wickizer TM, Shoben AB, Dong XS. A novel method for estimating the effects of job conditions on asthma and chronic lung disease. J Asthma. 2014 Oct; 51: (8)799-807.
    View PubMed
  113. Dembe AE, Yao X, Wickizer TM, Shoben AB, Dong XS. Using O*NET to estimate the association between work exposures and chronic diseases. Am J Ind Med. 2014 Sep; 57: (9)1022-31.
    View PubMed